60 DEGREES PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 0.90% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-30
- 60 DEGREES PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2025 was 0.90%.
- 60 DEGREES PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -8.00%.
- 60 DEGREES PHARMACEUTICALS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2025-12-31 | 0.90% 10-K · filed 2026-03-30 |
| 2023-12-31 | -8.00% 10-K · filed 2025-03-27 |
| 2022-12-31 | 0.00% 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |